COVID-19. Covid-19
Conditions
Interventions
Intervention 1: Intervention group: 34 patients receive herbal treatment including 150 ml of decoction (Matricaria chamomilla L., Zataria multiflora Boiss., Glycyrrhiza glabra L., Ziziphus jujuba Mill
Sponsors
Tehran University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: Patients with one or more of the following symptoms in addition to acute respiratory disease (ARI):• RR> 30• PO2 <93%• Pulmonary infiltration in chest x-ray• Clinical judgment of a specialist Age range of 18 to 75 years in both genders Lack of any serious concomitant disease of the heart, brain, or lungs, metabolic disorders, and etc. The patient’s ability and own will to fill out a personal consent form for inclusion in the study Patient not intubated.
Exclusion criteria
Exclusion criteria: Pregnancy and lactation Any history of allergy to any of the herbal product components Inability to take a drug per-oral Any condition that precludes continuance of medical intervention based on the judgment of a physician. Need for intubation Nausea and vomiting and oral intolerance Resistant hypoxemia Reduced level of consciousness Hemodynamic instability Hypercapnia - respiratory fatigue Any manifestation of known side effects of any of the herbal product components
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| O2 saturation percentage. Timepoint: Clinical examination and pulse oximetry at baseline, days 3, 6, 9, 12 and 14. Method of measurement: Pulse Oximeter.;Lung inflammation. Timepoint: CT scan at baseline, days 7 and 14. Method of measurement: CT scan. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMehrdad Karimi
Tehran University of Medical Sciences
Outcome results
None listed